EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2

Ralf Kircheis iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27125317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ralf Kircheis. Beteiligte Einrichtung: Advanced Medical Solutions (AMS) Saal, 93342 Saal an der Donau, Germany. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Spike Glycoprotein, Coronavirus, Lymphocyte Antigen 96. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS-CoV-2 spike protein has been shown to activate Toll-like receptor 4 (TLR4), yet the precise molecular structures driving recognition and subsequent activation remain poorly defined. Here, we present in silico structural alignments and molecular docking simulations indicating potential spatial compatibility between the wild-type SARS-CoV-2 HR1HR2 fusion core and the human TLR4/MD-2 heterodimer. The computational models project candidate interfaces involving salt bridges, as well as polar and non-polar interactions, with both TLR4 and MD-2 dimerization partners, suggesting a theoretical topology compatible with the dimerization of two TLR4/MD-2 heterocomplexes. Notably, similar structural compatibility was modeled for related class I fusion proteins from other highly pathogenic viruses, including SARS-CoV, MERS-CoV, influenza viruses A, B, and C, respiratory syncytial virus (RSV), and partially Ebola virus. These findings offer an exploratory computational hypothesis regarding viral–host interactions with the host innate immune system, which can trigger immune recognition or detrimental hyperactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Spike Glycoprotein, CoronavirusLymphocyte Antigen 96HumansSARS-CoV-2Molecular Docking SimulationComputer SimulationAmino Acid SequenceCOVID-19Protein MultimerizationProtein Binding

Stichwörter der Autor:innen

COVID-19Ebola virusHR1HR2 fusion coreSARS-CoV-2 spike proteinimmune hyperactivationinfluenza virusmolecular dockingrespiratory syncytial virus (RSV)toll-like receptor (TLR)

Substanzen

Toll-Like Receptor 4Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Lymphocyte Antigen 96TLR4 protein, humanLY96 protein, human

Autor:innen und Institutionen

  • Advanced Medical Solutions (AMS) Saal, 93342 Saal an der Donau, Germany.

ORCID-Profile: Ralf Kircheis

Zitieren

APA

Kircheis, R. (2026). In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125317

Vancouver

Kircheis R. In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27125317

BibTeX
@article{Kircheis2026,
  author = {Kircheis, Ralf},
  title = {In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27125317}
}
Kostenlos starten →